Cambricon
688256
Ping An Insurance
601318
China Vanke Co.,Ltd.
000002
4
Kweichow Moutai
600519
5
Semiconductor Manufacturing International Corporation
688981
CN Stock MarketDetailed Quotes
600161 Beijing Tiantan Biological Products Corporation
- 20.93
- +0.28+1.36%
Not Open Jan 23 15:00 CST
41.39BMarket Cap32.50P/E (TTM)
21.14High20.64Low165.40KlotVolume20.81Open20.65Pre Close345.67MTurnover0.84%Turnover Ratio37.31P/E (Static)1.98BShares27.6052wk High3.89P/B41.39BFloat Cap18.8852wk Low22.72Limit Up1.98BShs Float36.84Historical High18.59Limit Down2.42%Amplitude-0.04Historical Low0.13Dividend TTM20.90Avg Price74.16KlotAsk0.60%Div YieldTTM100Lot Size86.61KlotBid
Beijing Tiantan Biological Products Corporation Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -19.20%4.02B | 1.57%3B | -4.90%1.35B | 53.35%6.27B | 66.13%4.97B | 42.03%2.95B | 68.20%1.42B | 9.90%4.09B | 10.16%2.99B | 14.07%2.08B |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39,350.12%37.04K | ---- | ---- |
| Cash received relating to other operating activities | 38.50%107.31M | 23.54%65.05M | 32.70%38.37M | -34.98%105.52M | -23.75%77.48M | -26.97%52.65M | -29.55%28.91M | 6.97%162.28M | 8.33%101.61M | 15.83%72.1M |
| Cash inflows from operating activities | -18.32%4.13B | 1.95%3.06B | -4.14%1.39B | 49.98%6.37B | 63.18%5.05B | 39.72%3B | 63.66%1.45B | 9.78%4.25B | 10.10%3.1B | 14.13%2.15B |
| Goods services cash paid | 8.41%1.57B | 12.89%1.02B | 25.42%514.91M | 33.57%2.02B | 25.42%1.45B | 19.64%902.19M | 18.66%410.54M | 14.95%1.51B | 17.19%1.15B | 24.99%754.12M |
| Staff behalf paid | 5.31%605.23M | 10.19%412.64M | 14.72%225.64M | 18.08%1.09B | 14.75%574.7M | 15.77%374.49M | 12.69%196.69M | 5.15%921.27M | 5.91%500.81M | 0.77%323.49M |
| All taxes paid | 9.18%476.84M | 3.32%304.07M | -20.01%112.22M | 41.17%582.34M | 50.29%436.74M | 64.58%294.29M | 46.45%140.29M | 6.66%412.52M | 1.53%290.59M | -8.39%178.81M |
| Cash paid relating to other operating activities | -30.05%175.47M | -25.06%120.76M | -17.00%65.02M | 4.47%290.75M | 27.09%250.86M | 25.45%161.15M | 29.92%78.34M | -11.01%278.3M | -14.84%197.39M | -5.05%128.45M |
| Cash outflows from operating activities | 4.32%2.83B | 7.15%1.86B | 11.13%917.79M | 27.41%3.98B | 26.46%2.71B | 25.07%1.73B | 22.06%825.87M | 8.06%3.12B | 8.46%2.14B | 10.36%1.38B |
| Net cash flows from operating activities | -44.52%1.3B | -5.12%1.21B | -24.47%468.82M | 112.57%2.39B | 145.83%2.34B | 66.23%1.27B | 199.46%620.7M | 14.86%1.13B | 13.95%952.36M | 21.65%765.16M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --25.33M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | -36.30%21.5M | -36.30%21.5M | ---- | 50.00%33.75M | 50.00%33.75M | 50.00%33.75M | ---- | --22.5M | --22.5M | --22.5M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 32.81%132.73K | 150.41%49.6K | --44.34K | -56.33%312.08K | -59.68%99.94K | -12.74%19.81K | ---- | -91.60%714.57K | 1,523.27%247.87K | 65.69%22.7K |
| Cash received relating to other investing activities | -33.33%1B | -33.33%1B | ---- | 50.00%1.5B | 50.00%1.5B | 50.00%1.5B | ---- | 622,477.36%1B | --1B | --1B |
| Cash inflows from investing activities | -31.74%1.05B | -33.40%1.02B | --44.34K | 49.93%1.53B | 49.97%1.53B | 50.00%1.53B | ---- | 11,698.97%1.02B | 6,697,659.49%1.02B | 7,463,569.34%1.02B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 0.52%734.28M | 14.11%548.24M | 38.10%278.09M | -20.42%1.08B | -11.29%730.46M | -11.42%480.46M | -24.35%201.37M | 19.65%1.35B | 24.08%823.42M | 46.46%542.39M |
| Net cash paid to acquire subsidiaries and other business units | 227.77%5.16M | --5.16M | --5.16M | -95.67%1.58M | -95.67%1.58M | ---- | ---- | 23.28%36.36M | 23.95%36.36M | ---- |
| Cash paid relating to other investing activities | -68.74%532M | -70.59%500M | --500M | 13.17%1.7B | 13.08%1.7B | 13.33%1.7B | ---- | 50.01%1.5B | 50.19%1.5B | 50.00%1.5B |
| Cash outflows from investing activities | -47.76%1.27B | -51.69%1.05B | 288.96%783.26M | -3.91%2.78B | 2.92%2.43B | 6.76%2.18B | -24.35%201.37M | 31.93%2.89B | 38.29%2.36B | 47.05%2.04B |
| Net cash flows from investing activities | 75.06%-224.48M | 95.07%-31.85M | -288.93%-783.21M | 33.35%-1.25B | 32.93%-900.03M | 36.59%-646.69M | 24.34%-201.37M | 14.37%-1.87B | 21.52%-1.34B | 26.57%-1.02B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.97%1M | -99.97%1M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 66.67%1M | --1M | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.97%1M | -99.97%1M | ---- |
| Borrowing repayment | ---- | ---- | ---- | 240.70%366.25M | 237.96%181.65M | 4.65%56.25M | ---- | -67.05%107.5M | -80.80%53.75M | -80.80%53.75M |
| Dividend interest payment | 273.54%352.16M | 4,423.10%351.15M | ---- | -50.39%122.23M | -38.76%94.28M | -27.51%7.76M | -26.70%3.96M | 28.38%246.4M | -1.08%153.93M | -93.01%10.71M |
| -Including:Cash payments for dividends or profit to minority shareholders | 6,923.95%104.99M | --103.98M | ---- | -68.37%28.21M | 48.34%1.49M | ---- | ---- | 217.60%89.19M | -51.71%1.01M | ---- |
| Cash payments relating to other financing activities | 28.56%14.14M | 2.93%7.05M | 7.68%2.01M | -22.54%19.6M | -38.39%11M | -52.03%6.85M | -34.30%1.87M | -36.80%25.3M | -44.17%17.85M | -50.44%14.28M |
| Cash outflows from financing activities | 27.66%366.3M | 405.46%358.2M | -65.43%2.01M | 33.99%508.08M | 27.22%286.93M | -10.00%70.87M | -29.33%5.83M | -32.07%379.2M | -51.77%225.53M | -82.96%78.74M |
| Net cash flows from financing activities | -27.66%-366.3M | -405.46%-358.2M | 65.43%-2.01M | -34.34%-508.08M | -27.79%-286.93M | 10.00%-70.87M | 29.33%-5.83M | -113.63%-378.2M | -107.84%-224.53M | -102.74%-78.74M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -2,307.66%-62.39K | 14.44%15.29K | 105.51%1.08K | 99.32%-325.19 | -55.78%2.83K | 99.37%13.36K | ---19.52K | -333.78%-47.91K | 157.86%6.39K | 160.69%6.7K |
| Net increase in cash and cash equivalents | -38.67%707.91M | 47.33%816.7M | -176.52%-316.41M | 156.86%638.58M | 287.92%1.15B | 266.25%554.34M | 715.86%413.47M | -171.55%-1.12B | -130.86%-614.19M | -115.80%-333.45M |
| Add:Begin period cash and cash equivalents | 29.11%2.83B | 29.11%2.83B | 29.11%2.83B | -33.86%2.19B | -33.86%2.19B | -33.86%2.19B | -33.86%2.19B | 89.83%3.32B | 89.83%3.32B | 89.83%3.32B |
| End period cash equivalent | 5.74%3.54B | 32.78%3.65B | -3.50%2.52B | 29.11%2.83B | 23.87%3.35B | -7.89%2.75B | -19.77%2.61B | -33.86%2.19B | -27.68%2.7B | -22.65%2.98B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.